source
- FDA greenlights Pfizer/Arvinas breast cancer therapy vepdegestrant despite modest trial resultsThe U.S. Food and Drug Administration announced approval of vepdegestrant, a therapy developed by Pfizer and Arvinas, for a specific subtype of breast cancer. The decision comes even though the cl…
- Amgen initiates three late-stage trials of obesity shot MariTide, including a switch-patient studyAmgen announced the start of three new Phase 3 trials for its long-acting obesity injection, MariTide. One of the studies will enroll participants who are transitioning away from the GLP-1 therapi…